Public Health
Volume 123, Issue 12 , Pages 787-788 , December 2009

Aspirin for the primary prevention of vascular events?

  • G. Morgan

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 1554 744400; fax: +44 1554 744401.

Received 13 July 2009 ,Revised 27 September 2009 ,Accepted 12 October 2009.

References 

  1. Antithrombotic Trialists' Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849–1860
  2. St Elsewhere's NHS Trust . UK Comparative Audit of Upper Gastrointestinal Bleeding and the Use of Blood. London, UK: British Society of Gastroenterology; 2007;Available at: http://www.bsg.org.uk/clinical/general/uk-upper-gi-bleeding-audit.html(last accessed 07/09/2009)
  3. Bulugahapitiya U, Siyambalapitiya S, Sithole J, Fernando DJ, Idris I. Age threshold for vascular prophylaxis by aspirin in patients without diabetes. Heart. 2008;94:1429–1432
  4. Sattar N, Murray HM, Welsh P, Blauw GJ, Buckley BM. Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?. PLoS Med. 2009;6:e1000099
  5. Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, et al. Oxford Vascular Study. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 2005;366:1753–1754
  6. Gøtzsche PC, Hartling OJ, Nielsen M, Brodersen J, Jørgensen KJ. Breast cancer screening: the facts – or maybe not. BMJ. 2009;338:b86
  7. Longley M. Elwood P. My health: whose responsibility? A jury decides. J Epidemiol Community Health (in press).
  8. Hermida RC, Avala DE, Mojon A, Fernandez JR. Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. Am J Hypertension. 2009;22(8):896–903
  9. International consensus statement on aspirin and NSAIDs for cancer prevention. Lancet Oncol. 2009;10:501–507
  10. Morgan GP. Ethical considerations in relation to aspirin prophylaxis. Qual Prim Care. 2008;6:433–440

PII: S0033-3506(09)00288-1

doi: 10.1016/j.puhe.2009.10.007

Public Health
Volume 123, Issue 12 , Pages 787-788 , December 2009

Article Tools